(Crystal Detection Time 14 days). Slow-nucleating biles were not affected. The effect could not be related to the content of known pronucleating proteins (IgA, IgM, haptoglobin, aminopeptidase N and al-acid glycoprotein), since the slow-nucleating biles contained similar amounts of these proteins. Conclusions: Although Concanavalin A-binding fraction always accelerated crystallization when added to model bile, removal of the same fraction from native bile often had no effect. We conclude that slow-nucleating biles in particular contain undetermined factors which regulate the activity of pronucleators.
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in bile, because the proteins isolated from bile of cholesterol gallstone patients have been shown to affect crystal formation in model bile (13) . Employing Concanavalin A (ConA)-Sepharose affinity fractionation, it became possible to separate mucin from other glycoproteins in bile (14) (15) (16) . Several proteins were isolated from the ConA-Binding fraction (CABF) and their effect on crystallization was studied. This effect was determined by comparing the CDT of model bile with and without addition of the different proteins. The results of these studies indicated that added immunoglobulins (6, 17) , cr 1 -acid glycoprotein (7), aminopeptidase N (818) and haptoglobin (19) promote cholesterol crystallization in model biles. In addition to crystallization-promoting proteins, inhibitors have been isolated from CABF (3, 4, 20, 21) .
Despite the fact that many glycoproteins that putatively influence cholesterol crystallization have been isolated from CABF, the physiological relevance of these factors has not been established. A more appro-priate way to assess the importance of a factor in cholesterol crystallization is to remove it selectively from native bile. Gallinger et al. (22) removed mucin by ultrafiltration or ultracentrifugation of native bile from cholesterol gallstone patients and could not detect an effect on CDT, even though mucin added to model bile accelerated CDT This illustrates why the relative importance of other putative promoters and inhibitors is best evaluated by extraction of these proteins one by one from various native bile samples to determine their effect on crystallization kinetics. So far, this procedure has not been carried out successfully for ConA-binding protein.
In practice, such a procedure is difficult to accomplish, because large volumes of bile are required and selective extraction of only one protein is not always possible. In the present study, we therefore adopted a more rigorous approach. By incubating bile with ConA-Sepharose, almost all putative promoting and inhibiting proteins which bind to ConA were removed in one step, and the effect on cholesterol crystallization could be studied.
Materials and Methods

Materials
Concanavalin A-Sepharose and Sepharose 4B were obtained from Pharmacia AB (Uppsala, Sweden). Rabbit anti-human IgA (a-chain and secretory component), rabbit anti-human IgM (p-chain), rabbit anti-human al-acid glycoprotein, rabbit anti-human haptoglobin and peroxidase-conjugated rabbit anti-human heavychain IgA and IgM were obtained from DAK0 (Copenhagen, Denmark). Goat anti-human al-acid glycoprotein was obtained from Sigma Immuno Chemicals (St. Louis, MO, USA). Rabbit anti-human IgM for sandwich ELISA and standard plasma were purchased from Behring (Marburg, Germany). Cholesterol, egg yolk phosphatidylcholine and taurodeoxycholate were obtained from Sigma (St Louis, MO, USA). Taurocholate was from Fluka BioChemika (Buchs, Switzerland). Spectra/Par dialysis membranes with a cutoff of 12-14 kD were obtained from Spectrum Medical Industries (Houston, Texas, USA). Ultrafilters with a cutoff of 10 kD, (YM 10) were from Amicon (Danvers, MA, USA). Dynagard filters with a cutoff of 0..2 pm were from Microgon (Laguna Hills, CA, USA). Microtiter plates with medium binding capacity were purchased from Greiner (Frickenhausen, Germany). All other reagents used were of analytical grade.
Bile
Gallbladder bile was collected from 23 patients (patient characteristics: Table 1 ) at laparoscopic cholecystectomy for cholelithiasis. All patients were confirmed 
Gallstone content
Before the gallbladders were taken to the pathology department, the gallstones were removed, measured and counted; three patients had a solitary stone, seven patients had 2-3 stones and 13 patients had 4 or more stones. Gallstones from all patients were air-dried, crushed and assayed for cholesterol content. One milligram of stone-powder was dissolved in 1 ml iso-propano1 and sonicated for 1 h. Cholesterol content was determined using a standard enzymatic procedure. Cholesterol stones were defined to be greater than 70% cholesterol by weight. Only biles from patients with cholesterol stones (n=23) are considered in this article. The mean cholesterol content of the stones was 92% (range 766100).
Extraction of CABFfrom bile
Fresh human gallbladder bile was centrifuged (10 min, 2000 rpm) and two portions of 3 ml were taken. The remaining bile was stored at -20°C for determination of lipid and protein composition. From one of the 3-ml portions, CABF was removed using ConA-Sepharose-4B. The ConA-Sepharose beads were prewashed three times with ConA-buffer containing 0.2 M NaCl, 10 mM Tris (pH 7.4) 1 mM MnC12, 1 mM CaClz and 1 mM MgCl* and 0.02% NaN,. The beads were pelleted (5 min, 2000 rpm) and the supernatant was carefully removed completely. Three milliliters of bile were added to 1.5 ml packed beads, mixed thoroughly and incubated for 2 h on a roller bank at 20°C. As a control, the other portion of bile was added to 1.5 ml washed packed Sepharose 4B beads and subjected to the same procedure.
Effect of ConA-binding proteins in native bile
After 2 h of incubation on a roller bank at room temperature, the beads with the bile samples were centrifuged for 15 min at 1200 rpm. Supernatant from both ConA and control Sepharose beads was passed through an 0.22 pm Millipore (Millex-GS) filter into a sterile container. Each filtrate was incubated at 37°C to determine CDT. To be able to discriminate between the effects on nucleation and crystal growth, we also examined the result of CABF extraction in biles from which crystals were not removed (unfiltered bile) prior to the crystal detection assay. In 11 separate bile samples the effect of CABF extraction was studied not only in filtered but also in unfiltered bile. The rest of the supernatant was stored at -20°C. The beads were washed three times with 10 ml ConA-buffer and subsequently stacked in a 1 X 5 cm column, washed again with 15 ml ConA-buffer containing 0.1 M a-D-methylmannopyranoside. The eluate was concentrated on an Amicon-filter (YMlO) until approximately 1 ml was left. To remove 0.1 M cx-Dmethylmannopyranoside, the concentrate was diluted again with 15 ml HEPES buffer (50 mM, pH 7.4), followed by concentration. This procedure was repeated three times. After the final cycle, the concentrate was reconstituted to the volume of the initial sample; i.e. 3 ml.
Crystal detection time and crystal growth determination
In many samples there was insufficient bile for a control incubation of untreated native bile. We therefore compared the effect of incubation with Sepharose in parallel experiments. The effect of incubation with Sepharose beads was studied by comparison in 5 paired bile samples of the CDT in ultrafiltered biles incubated with Sepharose beads with the CDT of untreated ultrafiltered biles.
The bead-treated samples were incubated without shaking at 37°C for a maximum of 21 days. A sample of 10 ~1 was examined daily. The samples were observed under a light microscope with polarized light at a 100X magnification. The presence of cholesterol monohydrate crystals was determined and if they were present, the number of crystals was counted using a hemocytometer. The crystal detection time (CDT) and the maximum rate of crystal formation (C,,,) were determined. CDT was defined as the day on which the first cholesterol crystal was observed in a bile sample. C max was defined as the maximal slope of the curve showing the relation between crystal number and time.
Determination of the extraction efficacy of the Concanavalin A-Sepharose beads
The efficacy of protein extraction with ConA-Sepharose has been tested previously with gel electrophoresis and Western blotting. No protein could be demonstrated in the eluate of bile that had been loaded on a ConA-Sepharose column (14) . In the present study we additionally tested the efficacy of Concanavalin A-Sepharose fractionation by determining the extraction of two important Concanavalin A-binding proteins: IgA and haptoglobin. Using an ELISA (see below), IgA and haptoglobin were measured in the supernatant of both ConA-Sepharose-treatedand Sepharose-treated bile. The amount of IgA and haptoglobin found in the ConA-treated bile divided by the amount found in Sepharose-treated bile was considered a measure for the extraction-efficacy of CABE
Determination of the effect of the different extracted proteins on crystal appearance time in model bile
For the preparation of supersaturated model bile with a cholesterol saturation index (CSI) of 1.6, taurocholate and taurodeoxycholate were dissolved in methanol/water (85:15) and mixed with lecithin in chloroform. After addition of cholesterol in chloroform, the mixture was dried under nitrogen at 50°C to evaporate the organic solvents and then subsequently lyophilized. The dry lipid film was solubilized in HEP-ES buffer (50 mmol/l, pH 7.4) containing 100 mmol/l NaCl and 0.02% NaN3 and equilibrated for 2 h at 56°C. Each eluate from the ConA-Sepharose-treated bile samples was mixed with an equal volume of model bile. The mixtures were filtered over a 0.2 pm ME Dynagard filter and incubated at 37 "C. At different time points the cholesterol crystal mass in the samples was measured at 840 nm, using a (Behring BN 100) nephelometer. Light scattering was calculated as total crystal mass in ,ug/ml according to a linear standard curve. Crystallization curves were fitted with the computer program Fig-P (Biosoft, Ferguson, MO) by using a sigmoidal model (Hill type equation).
ELISA
The amount of four glycoproteins (&A, IgM, haptoglobin and crl acid glycoprotein), was measured separately in the different bile fractions. Microtiter plates were coated with rabbit antihuman IgA (1:5000) or rabbit antihuman IgM (l:lOOO), goat antihuman haptoglobin or goat anti-human al acid glycoprotein respectively, for 16 h at 4°C. The plates were washed twice with PBS/Tween (0.05%, v/v). Blocking was obtained with 1% (w/v) BSA in PBS/Tween 0.05% for 1 h at 37°C. After washing twice with PBS/Tween 0.05%, the wells were incubated with serially-diluted samples (in PBS/Tween with 0.1% BSA) or standard plasma for 2 h at 37°C. For haptoglobin and al acid glycoprotein, this procedure was followed by incubation with rabbit anti-human haptoglobin (1:3000) or anti-a:1 acid glycoprotein (1:2000). After washing four times in PBS/ Tween, incubation followed by peroxidase-conjugated rabbit antihuman, IgA (1:3000) or IgM (l:lOOO), or peroxidase-conjugated goat anti-rabbit IgG (1:3000) diluted in PBS/Tween buffer containing 0.1% BSA for 1 h at 37°C. Color development was performed with 0.1 mg/ml 3,3',5,5'-tetramethylbenzidine, 0.0036% H202 and 0.1 mol/l sodium acetate, pH 5.5.
The intra-assay coefficient of variance and inter-assay coefficient of variance in all ELISA procedures described were less than 8 and lo%, respectively.
Aminopeptidase N Levels of aminopeptidase N were determined by measuring its enzymatic activity for hydrolysis of Lalanyl-B-naphthylamide. The /3-naphthylamide product was determined fluorometrically (excitation 340 nm, emission 410 nm) (23) .
Protein and lipid composition
Protein in gallbladder bile was determined by the method of Bradford (24) after delipidation according to Wessel & Fltigge (25) . Protein in the Concanavalin A-binding fraction was determined directly by the method of Bradford (24) . Cholesterol, phospholipid and bile-salt concentrations were determined using standard enzymatic procedures (26) (27) (28) . Cholesterol saturation indices were calculated according to Carey's critical tables (29) .
Statistical analysis
Statistical evaluations were performed with the MannWhitney U-test between groups and the Wilcoxon Signed Rank Test within groups. Data are given as mean?SE.
Results
Efficacy of the Concanavalin A-extraction method
To investigate the capacity of ConA-Sepharose in the experimental set-up used, the extraction of two important ConA-binding proteins, IgA and haptoglobin, was determined. The extraction efficacy was 96? 1.9% for IgA and 98? 1.2% for haptoglobin. Although bile samples were added to packed beads, some dilution was inevitable due to the fluid in and adhering to the beads. We therefore measured the lipid content of the samples before and after addition of both Sepharose and ConA-Sepharose. Treatment, whether ConA or plain Sepharose, induced comparable reductions in the contents of bile salts (39%) in phospholipids (25%) and in cholesterol (15%), resulting in an increase of the CSI of about 30% ( Table 2) . Incubation of bile with Sepharose beads did not result in a significant change in CDT compared to untreated ultrafiltered bile (4.2t 1.7 days and 4.8? 1.3 days, respectively).
Crystal detection time and the maximum rate of crystal formation
Removal of CABF from the bile samples caused prolongation or no change in CDT. The size of the crystals as observed under the microscope was comparable between paired Sepharose and ConA-treated bile samples. Significant acceleration of CDT by removal of CABF was never observed, indicating that none of the biles contained a surplus of ConA-binding inhibiting factor.
The result of a typical experiment is shown in Fig.  1 . Removal of the CABF increased CDT from 1 to 4 days and dramatically reduced the number of crystals formed. Fig. 2 CDT, but dramatically decreased maximal crystallization.
To investigate whether the effect of the procedure was related to CDT, we separated the group into fast (CDT54 days) and slow nucleators (CDT24 days), as suggested by Jtingst et al. (30) . The mean CSI of the slow-nucleating biles (1.43 kO.13) was not significantly different from the CSI of fast-nucleating biles (1.74kO.30, p=O.62, Table 3 ). Removal of the CABF had no significant effect on CDT or C,, in slownucleating biles (Fig. 3) . In contrast, in the fast-nucleating biles a clear effect was observed on both CDT Fig. 2 and Cm,, (Fig. 4) . The mean CDT increased from 1.720.3 to 4.220.9 days (p=O.Ol), whereas the mean C max decreased from 106+42 to ll+lO crystals per hour QKO.002). Note that C,,, was more than 100X faster for the fast-compared to the slow-nucleating biles.
Fig. 3. Crystal Detection Time (CDT) and maximum rate of crystal formation (C,,,) in slow-nucleating bile samples in the absence and presence of the Concanavalin A-binding Fraction (CABF). Data are derived from the group presented in
In the procedure described above, to remove cholesterol crystals, the samples are filtered through a 0.22 pm filter after incubation with Concanavalin A-Sepharose or Sepharose. To investigate the influence of this, we omitted the filtration step in 11 bile samples and compared the results with the procedure with filtration. There was no significant difference in the effect of CABF extraction on C,, in filtered and unfiltered bile (Fig. 5) . Of course, determination of CDT is meaningless in unfiltered samples.
To establish whether the effect on CDT and the effect on C,,, could be explained by the same factor in the CABF, we determined if there was a correlation between the effect of extraction of the CABF on the CDT and the effect of CABF extraction on C,,,. results are plotted in Fig. 6 where the percentage increase in CDT is plotted against the percentage decrease in Cmax. No significant relation (r=0.38, p= 0.08) was observed between CDT and decrease of C max, because in 6 samples removal of CABF produced a large decrease in C,,, with no effect on CDT, suggesting that more than one factor in CABF is involved in regulating crystallization. 
Fig. 4. Crystal Detection Time (CDT) and maximum rate of crystal formation (C,,, in fast-nucleating bile samples in the absence and presence of the Concanavalin A-binding Fraction (CABF
Correlation between five dtfferent Con A-binding glycoproteins and the effect on CDT and C,,,,,
To investigate if one of the known ConA-binding promoting proteins was mainly responsible for the effect that extraction of the CABF had on CDT and C,,,, the contents of IgA, IgM, al-acid glycoprotein, aminopeptidase N and haptoglobin were measured in the native bile samples (Table 4 ). The mean total amount of protein in the bile samples was 2.9 g/l (range 0.6-12.2). All individual proteins except IgM (r=0.3, p=O.13) correlated highly (r=O.5-0.8, ~50.01) with total protein. Subsequently, the concentrations of the different proteins were plotted against the CDT and against the effect extraction of the CABF had on CDT and C,,,.
No correlation was found between the amount of IgA, zation-promoting activity was determined in the crysIgM, haptoglobin al-acid glycoprotein, aminopeptidatal growth assay. Figure 7 shows the activity for 5 se N or the total amount of protein and either CDT samples derived from fast-nucleating biles and 5 or the effect of extraction.
samples from slow-nucleating biles.
Eluate of isolated CABF on crystallization in model bile
To be able to correlate the crystallization-promoting activity of CABF in native bile with the activity in a model bile system, we eluted the bound fraction from the ConA-Sepharose beads and, after dialysis, concentrated back to the initial volume. The CABF were mixed 1:l with a supersaturated model bile, and crystalli- 
Efect of ConA-binding proteins in native bile
The addition of CABF accelerated and decreased crystal appearance time in all cases, but the magnitude of the effect varied considerably from patient to patient, and there was no significant difference between slow-and fast-nucleating native bile samples. Eluates from control Sepharose columns were tested as well, but showed no activity. We also incubated model bile with ConA-Sepharose beads. The eluate of this incubation was tested but showed no activity.
Discussion
Crystallization of cholesterol in bile is an extremely complex process involving a multitude of biliary components. In the early eighties a role for proteins in this process was proposed (31) . Despite intensive research, conclusive evidence for the importance of proteins in the crystallization process is still lacking. We have attempted but failed to eliminate possible important nucleating proteins one by one from the bile, by using immunoaffinity chromatography, probably because biliary components interfere with the antibody-antigen interaction. In this study we therefore used a more rigorous approach and simply removed all Concanavalin A-binding proteins by using Con A-Sepharose. The results were surprising. Of the 23 bile samples tested, only 10 showed a significant effect of removal of CABE These bile samples nucleated quickly and showed, in most cases, fast crystal growth. The effect of CABF extraction was more pronounced on crystal growth than on CDT. Interestingly, some samples showed only an effect on CDT and no decrease in crystal growth, indicating the influence of more than one activating factor.
The validity of the method is based on two assumptions. Firstly, extraction of protein should be highly effective; otherwise, when present in great excess, incomplete removal of a promoter will have relatively little effect on its crystallization activity. Secondly, the procedure should not selectively influence biliary lipid composition. Incubation of bile with column material inevitably leads to dilution. We therefore controlled our procedure by incubating a parallel bile sample with Sepharose 4B. It has been reported that Concanavalin A binds hydrophobic compounds. In the present study, we observed no difference between the incubation with Sepharose or ConA-Sepharose. Interestingly, the CSI of the bile increased after incubation with column material; depletion was greatest for bile salts. Apparently, the distribution volume is much larger for simple and mixed micelles than for vesicles. The pores in the beads are too small for the vesicles.
ConA-Sepharose extraction proved to be highly efficient. The major protein in CABF, IgA, was 95% removed, and haptoglobin was 98%. However, since extraction was not lOO%, the influence of CABF on crystallization may have been somewhat underestimated. When one of the promotors serves as a nucleation nidus, the residual presence of about 5% could explain why particularly the number of crystals formed is affected, whereas the influence on CDT was somewhat less pronounced.
Slow-nucleating bile samples were not significantly influenced by CABF removal. We therefore conclude that in these samples crystallization is not controlled by ConA-binding protein. CABF has been shown to contain inhibitory proteins (3,4), in addition to the pronucleating activity. It can thus not be ruled out completely that the removal of compensating activities explains the lack of effect, but we consider this possibility highly unlikely. Firstly, CDT has been shown to be unaffected by pronase digestion of protein; the inhibitors proposed so far are all sensitive to proteolytic degradation (32) . Secondly, it seems highly unlikely that pro-and antinucleating activity would always be exactly in balance. We propose that in the slow-nucleating samples either the lipid components control the nucleating process or inhibitors are present which specifically block the activity of CABE Interestingly, a number of fast-nucleating, slowly growing samples also show a lack of CABF influence. In these samples either non-Con A-binding proteins are active or cholesterol saturation is the main controlling factor. Indeed, in the samples not responding to removal of CABF a significant correlation between CDT and CSI was observed (v=-0.55, p=O.O5).
In two recent studies (33, 34) , it has been shown that CABF can contain cholesterol crystals. The origin of these crystals is not clear; presumably they form during elution of the bound glycoproteins from lipoprotein particles. We have shown before that, when testing activity of CABF in model bile, the presence of such crystals does not significantly influence promoting activity in our experimental setup because they are removed by a filtration step (35) . In principle, formation of cholesterol crystals during the incubation in native bile with ConA-Sepharose will also not influence the type of study, presented here, because they are removed anyway at the start of the nucleation assay. We have, however, shown previously that ultracentrifugation or ultrafiltration of bile does not rigorously remove all micro-crystals present in bile (35) . If these micro-crystals do bind to ConASepharose and are present only in fast-nucleating biles, this could explain part of the effect in these biles. To investigate this possibility, we tested the effect of ConA-Sepharose on crystallization in bile from which crystals were not removed prior to the procedure. Of course, an effect on CDT cannot be studied under these conditions, but a specific effect of the proteins on crystal growth should still be apparent. As shown in Fig. 5 , there was no significant difference in the effect on inhibition of crystal growth, whether or not crystals were present at the onset of the crystal detection assay. To address the question which factor is responsible for the activity seen in CABF, we chose two independent strategies. First the concentration of the previously reported nucleating factors was determined in all bile samples. Secondly, total promoting activity in CABF was determined in a model bile system. There was no correlation between the concentration of the promotors in native bile and the ability to influence crystallization parameters. The data were analyzed using multi-variate analysis. No correlation was found between the content of IgA, IgM, al-acid glycoprotein, aminopeptidase N or haptoglobin and the degree of influence of removal or addition on either CDT or crystal growth. In an earlier study, we quantified the crystallization-promoting activity by assessing the so-called Nucleation Promoting Activity Titer (36) . In the present study, activity was quantified using the much less laborious assay system developed by Busch et al. (37) . In accordance with our earlier study, promoting activity was found in all CABFs, although there was variation among patients. Since we had only three singlestone patients in this group, we did not test whether the activity in these patients was lower.
Surprisingly, the samples which showed no effect of CABF-extraction also had considerable promoting activity in the isolated fraction. We can only speculate about possible explanations for this paradoxical finding. The lack of effect of removal of CABF on crystallization kinetics was almost invariably found in slow-nucleating samples. It cannot be excluded that the crystallization path in these samples differs from the fast crystallizing samples. Proteins than do not influence this path. Perhaps a more plausible explanation is the presence of potent non-Concanavalin Abinding inhibitors in slowly-crystallizing bile. In the past decade, the group of Holzbach has proposed several inhibitory candidates, including apolipoprotein A I (38) and a helix pomatia binding 128 kD protein (4) and recently Busch et al. have added IgA and its secretory component to this list (39) . Except apolipoprotein A I, these proteins bind to Concanav-alin A and therefore cannot account for the observed results. We also do not consider a role for apolipoprotein A I very likely. Activity of the protein has been shown to be sensitive to protease treatment. Pattinson & Willis could not find an effect of pronase on crystallization in slow or fast-nucleating samples (40) . Activity of a pronase sensitive inhibitor should have led to acceleration of crystallization. We have shown that non-protein compounds such as FFA and BSP are potent inhibitors of promotor-induced crystallization (41, 42) . Whether organic anions or related compounds present in human bile are also capable of controlling cholesterol crystallization is presently under investigation.
Conclusions
In this study, we have shown that although bile from cholesterol gallstone patients always contains potent crystallization promotors, this activity controls cholesterol precipitation only in fast-nucleating biles. We speculate that this specific activity is inactivated in slowly-crystallizing supersaturated bile by as yet uncharacterized factor(s).
